Robin Carhart-Harris

Robin Carhart-Harris is a neuroscientist whose defining project was to make the mind’s less accessible regions available to experimental study: he brought questions about the unconscious into a laboratory equipped with psychedelics and brain imaging. At Imperial College London, his research found that psilocybin reduced activity in the default mode network, and that the largest reductions correlated with volunteers’ reports of ego dissolution. He developed these findings into the entropic brain theory, which treated the disruption of habitual patterns not simply as an effect of drugs, but as a way to investigate consciousness and potentially address rigid patterns of thought.

From psychoanalysis to neuroscience

Carhart-Harris’s route into psychopharmacology began with psychoanalysis. As a graduate student, he was drawn to Sigmund Freud and Carl Jung, but dissatisfied with psychoanalysis’s limited scientific rigor and its reliance on methods such as dreams and free association to investigate the unconscious. He wondered whether a drug might provide another means of access. A seminar professor directed him to Stanislav Grof’s Realms of the Human Unconscious, a book that made a lasting impression and helped set the course of his work.

He proposed combining psychedelic drugs with modern brain-imaging technology to give psychoanalytic ideas a firmer scientific basis. In his framing, psychedelics might extend the investigative role Freud had assigned to dreams: rather than displacing psychoanalysis, they could give researchers another means to examine processes that ordinary waking consciousness keeps less available. Carhart-Harris’s ambition was expansive, but his manner was described as modest and self-effacing; the contrast between his temperament and the reach of his project became a recurring feature of his scientific portrait.

After completing a master’s degree in psychoanalysis in 2005, he sought people able to help him move into psychedelic neuroscience. He approached Amanda Feilding, whose Beckley Foundation studied psychoactive substances and advocated drug-policy reform, and David Nutt, a psychopharmacologist with a laboratory at Imperial College London. Feilding invited him to Beckley Park. When Carhart-Harris first presented the plan to Nutt, Nutt considered it far-fetched and pointed out that the younger researcher lacked neuroscience experience. Carhart-Harris persisted. Nutt offered him a PhD position, beginning with a more conventional study of MDMA and the serotonin system, with psychedelic research as a possible later direction. The staged arrangement gave the ambitious project a practical entry point rather than immediate approval on its own terms.

The first brain-imaging findings

The later stage arrived in 2009. By then Carhart-Harris had completed his PhD and was working in Nutt’s laboratory with funding from Feilding. The team received approval from the National Health Service and the Home Office to study psilocybin’s effects on the brain; research with LSD followed several years later. Carhart-Harris offered to be the first volunteer, reasoning that he should experience the procedure before giving the drug to others and placing them in a scanner. Nutt discouraged him, both because Carhart-Harris described himself as anxious and because taking part might compromise his objectivity. A colleague became the first participant to receive psilocybin and enter the functional magnetic resonance imaging scanner.

Carhart-Harris expected the scans to show increased activity, particularly in areas associated with emotion, and anticipated a pattern resembling the dreaming brain. The initial measurements contradicted that expectation: they showed decreases in blood flow, a measure used in functional magnetic resonance imaging as a proxy for brain activity. A second measure, based on oxygen consumption, supported the same result. The reductions were concentrated in the default mode network, a system that Marcus Raichle had described in 2001 as a centrally situated hub connecting parts of the cerebral cortex with deeper structures involved in memory and emotion. The network is active during periods without a specific external task and is associated with daydreaming, rumination, reflection on the self, and mental travel through time.

The most striking result was the relationship between the network’s activity and participants’ reports. The steepest drops in default mode network activity correlated with the strongest experiences of ego dissolution. In other words, the more activity fell, the more likely volunteers were to describe losing their ordinary sense of self or of the boundary between themselves and their surroundings. Carhart-Harris published the findings in a 2012 paper on the neural correlates of the psychedelic state. The result gave researchers a measurable correlate for a subjective experience, without making the experience itself reducible to a scan.

The comparison with meditation sharpened the significance of the finding. Judson Brewer, who was using brain imaging to study experienced meditators, noticed that the scans resembled Carhart-Harris’s results: reported transcendence of the self was also associated with a quieter default mode network. This resemblance did not make psychedelic experience and meditation identical. It suggested, instead, that different practices might converge on a neural pattern associated with a temporary weakening of self-related activity. Carhart-Harris considered whether such a weakening could help explain why mystical experiences often feel like a merging of subject and world, and why insights during them can seem objectively revealed rather than merely personal.

The entropic brain theory

In 2014, Carhart-Harris set out a wider interpretation in The Entropic Brain: A Theory of Conscious States Informed by Neuroimaging Research with Psychedelic Drugs. The theory joined psychoanalysis to cognitive brain science through a question about the costs of mental order. Predictive processes help the adult brain manage uncertainty, anticipate events, and conserve resources; they support realism and foresight. But, in his account, the same stability can narrow cognition. The organized, self-reflective mind is useful, yet its habitual patterns may become too rigid.

Carhart-Harris proposed that some difficulties associated with depression, addiction, obsessive patterns, and eating disorders could involve excessive order rather than simply a lack of it. A highly active default mode network may sustain loops of self-focused rumination, leaving a person caught in repeated patterns of thought. Psychedelics, by quieting that network and increasing the brain’s entropy, might temporarily loosen those patterns and permit a less constrained mode of cognition. In this model, the change is not only that one system falls quiet: a more primary mode of consciousness may re-emerge, bringing normally less regulated mental material into view.

His account was not a simple celebration of altered states. Carhart-Harris resisted claims that psychedelic experience proves consciousness to be independent of the brain or a property of the universe. He interpreted the dissolution of the bounded self through a Freudian developmental framework, as a return to a more primitive mode of cognition, rather than an uncomplicated ascent to a higher reality. The distinction matters to his project: psychedelics could be scientifically valuable precisely because they alter familiar modes of consciousness, without their subjective force settling metaphysical questions about what consciousness ultimately is.

The theory also describes a spectrum rather than treating all forms of disorder as equivalent. Depression, addiction, and obsessive patterns fall, in his account, toward excessive order; psychosis lies toward excessive entropy. This distinction limits the therapeutic claim: if the proposed benefit comes from temporarily loosening rigid patterns, simply adding entropy would not be expected to help conditions already associated with too much of it. The framework therefore connects a possible treatment mechanism to a proposed account of why the same class of drugs might be inappropriate for some states.

From laboratory model to clinical questions

After publishing the entropy paper, Carhart-Harris sought to test the theory with patients. The Imperial laboratory extended its work from basic research to a small pilot study of psilocybin for treatment-resistant depression, supported by a grant secured by Nutt from the United Kingdom government. The move placed a new responsibility alongside the laboratory’s scientific aims: clinical work required attention to the patient’s welfare as well as the collection of data. In a separate, nonclinical LSD experiment, a volunteer named Toby Slater became anxious in the scanner, asked to leave, and later asked to leave again after returning. The episode exposed the tension between completing an experimental procedure and responding to a participant’s distress. It forms a cautionary counterpart to the therapeutic ambitions of the later pilot work.

Carhart-Harris’s proposed mechanism remained provisional. Research pointed to a possible chain involving psychedelic compounds’ affinity for serotonin 2A receptors, receptor-rich layer-five pyramidal neurons in the cortex, and disruption of the brain’s usual electrical rhythms. He compared the disruption of synchronized activity to applause losing its rhythm when some people clap out of time. In particular, changes to alpha-wave oscillations had been associated with default mode network activity and self-reflection. This account offered a plausible route from pharmacology to altered network activity, but it did not resolve exactly how psychedelics produce their effects.

Imaging work also suggested that the change was broader than the quieting of one network. Under psychedelics, specialized systems such as the default mode network and visual processing system became less distinct, while connections between regions that ordinarily communicated less directly increased. Carhart-Harris and his colleagues described the resulting brain activity as more flexible and interconnected. The entropic brain theory thus gave a conceptual interpretation to changes in both activity and connectivity: temporarily weakened specialization might make alternative patterns of communication possible.

The wider implications remained matters for investigation rather than guarantees of outcome. Imperial researchers found that psychedelic experience elevated volunteers’ scores on a measure of nature relatedness. A 2017 study reported that ego dissolution during a participant’s most intense psychedelic experience predicted greater openness and nature relatedness, along with more liberal and less authoritarian political views. These results describe associations, not proof that a psychedelic experience causes durable changes in personality or political belief. They nevertheless extend the questions raised by the first scans: if the ordinary sense of a separate self depends partly on a brain network whose activity can change, then the effects of that change may reach beyond the immediate experience of losing the self.

Significance

Carhart-Harris’s importance lies in treating psychedelic experience as both a subjective event and a possible object of neuroscientific measurement. The scans did not make reports of ego dissolution disappear into data; rather, they placed those reports in relation to observable changes in brain activity. His progression from psychoanalytic questions to psilocybin imaging, and from imaging to a theory of entropy and clinical research, made the default mode network a meeting point between accounts of selfhood, patterns of thought, and measurable neural activity.

That framework remains a proposal, not a complete explanation of consciousness or mental illness. Its force comes from the way it generates testable questions: whether entrenched patterns can be loosened, whether the resulting period of flexibility can support new learning, and which conditions might benefit from that change. Carhart-Harris’s work gave those questions a laboratory form, while its limits and clinical complications kept the promise of a brain-based account from becoming a claim that the scans had already supplied all the answers.